Homocysteine Metabolism and Associated Diseases*

Expand
  • (1Diabetes Institute, Department of Endocrinology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058,China; 2Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100191,China; 3 Department of Central Laboratory and Institute of Clinical Molecular Biology, Peking University People’s Hospital, Beijing 100044.China)

Online published: 2023-08-28

Supported by

 

Abstract

Genetic mutation, vitamin and folate deficiencies, diet high-calorie and renal impairment could induce homocysteine (Hcy) -associated metabolic disorders in multiple tissues (liver, kidney, etc.) and lead to increased plasma Hcy levels, finally resulting in hyperhomocysteinemia (HHcy). HHcy is closely related to the occurrence and development of various diseases. However, the underlying mechanisms are complex and poorly understood. This article reviews the relationship between Hcy metabolism and related diseases, discusses the latest advances in the mechanism underlying the disorders of Hcy metabolism, as well as the current state of disease treatment, further providing possible intervention strategies for the treatment of HHcy -associated diseases.

Cite this article

YAN Han1,XIANG Rui2,YANG Ji-Chun2,△,CHI Yu-Jing3,△ . Homocysteine Metabolism and Associated Diseases*[J]. Progress in Physiological Sciences, 2023 , 54(4) : 290 -296 . DOI: 10.20059/j.cnki.pps.2023.02.1042

References

 
Options
Outlines

/